Bifogade filer
Kurs & Likviditet
Kalender
2024-11-21 | Kvartalsrapport 2024-Q3 |
2024-08-22 | Kvartalsrapport 2024-Q2 |
2024-05-16 | Ordinarie utdelning WNT 0.00 SEK |
2024-05-15 | Årsstämma 2024 |
2024-05-03 | Kvartalsrapport 2024-Q1 |
2024-02-29 | Bokslutskommuniké 2023 |
2023-11-16 | Kvartalsrapport 2023-Q3 |
2023-08-17 | Kvartalsrapport 2023-Q2 |
2023-06-02 | Ordinarie utdelning WNT 0.00 SEK |
2023-05-11 | Årsstämma 2023 |
2023-05-04 | Kvartalsrapport 2023-Q1 |
2023-02-09 | Bokslutskommuniké 2022 |
2022-12-12 | Extra Bolagsstämma 2022 |
2022-11-17 | Kvartalsrapport 2022-Q3 |
2022-08-18 | Kvartalsrapport 2022-Q2 |
2022-06-02 | Årsstämma 2022 |
2022-05-06 | Ordinarie utdelning WNT 0.00 SEK |
2022-05-05 | Kvartalsrapport 2022-Q1 |
2022-02-09 | Bokslutskommuniké 2021 |
2021-11-18 | Kvartalsrapport 2021-Q3 |
2021-08-19 | Kvartalsrapport 2021-Q2 |
2021-05-07 | Ordinarie utdelning WNT 0.00 SEK |
2021-05-06 | Kvartalsrapport 2021-Q1 |
2021-05-06 | Årsstämma 2021 |
2021-03-10 | Extra Bolagsstämma 2021 |
2021-02-08 | Bokslutskommuniké 2020 |
2020-11-12 | Kvartalsrapport 2020-Q3 |
2020-08-13 | Kvartalsrapport 2020-Q2 |
2020-06-09 | Ordinarie utdelning WNT 0.00 SEK |
2020-06-08 | Årsstämma 2020 |
2020-05-19 | Kvartalsrapport 2020-Q1 |
2020-04-15 | Extra Bolagsstämma 2020 |
2020-02-20 | Bokslutskommuniké 2019 |
2019-11-14 | Kvartalsrapport 2019-Q3 |
2019-08-15 | Kvartalsrapport 2019-Q2 |
2019-06-14 | Årsstämma 2019 |
2019-05-31 | Kvartalsrapport 2019-Q1 |
2019-05-15 | Ordinarie utdelning WNT 0.00 SEK |
2019-03-19 | Extra Bolagsstämma 2019 |
2019-02-21 | Bokslutskommuniké 2018 |
2018-11-15 | Kvartalsrapport 2018-Q3 |
2018-08-16 | Kvartalsrapport 2018-Q2 |
2018-05-17 | Kvartalsrapport 2018-Q1 |
2018-05-16 | Ordinarie utdelning WNT 0.00 SEK |
2018-05-15 | Årsstämma 2018 |
2018-02-22 | Bokslutskommuniké 2017 |
2017-11-16 | Kvartalsrapport 2017-Q3 |
2017-09-20 | Extra Bolagsstämma 2017 |
2017-08-17 | Kvartalsrapport 2017-Q2 |
2017-05-19 | Ordinarie utdelning WNT 0.00 SEK |
2017-05-18 | Årsstämma 2017 |
2017-05-18 | Kvartalsrapport 2017-Q1 |
2017-02-24 | Bokslutskommuniké 2016 |
2016-11-25 | Kvartalsrapport 2016-Q3 |
2016-08-26 | Kvartalsrapport 2016-Q2 |
2016-05-30 | Ordinarie utdelning WNT 0.00 SEK |
2016-05-27 | Kvartalsrapport 2016-Q1 |
2016-05-27 | Årsstämma 2016 |
2016-02-29 | Bokslutskommuniké 2015 |
2015-11-27 | Kvartalsrapport 2015-Q3 |
2015-08-28 | Kvartalsrapport 2015-Q2 |
2015-06-10 | Ordinarie utdelning WNT 0.00 SEK |
2015-06-09 | Årsstämma 2015 |
2015-05-29 | Kvartalsrapport 2015-Q1 |
2015-02-27 | Bokslutskommuniké 2014 |
2014-11-28 | Kvartalsrapport 2014-Q3 |
2014-08-29 | Kvartalsrapport 2014-Q2 |
2014-06-12 | Ordinarie utdelning WNT 0.00 SEK |
2014-06-11 | Årsstämma 2014 |
2014-05-30 | Kvartalsrapport 2014-Q1 |
2014-04-23 | Analytiker möte 2014 |
2014-02-28 | Bokslutskommuniké 2013 |
2013-11-29 | Kvartalsrapport 2013-Q3 |
2013-08-30 | Kvartalsrapport 2013-Q2 |
2013-06-19 | Ordinarie utdelning WNT 0.00 SEK |
2013-06-18 | Årsstämma 2013 |
2013-05-31 | Kvartalsrapport 2013-Q1 |
2013-03-19 | Analytiker möte 2013 |
2013-02-25 | Bokslutskommuniké 2012 |
2013-02-25 | Extra Bolagsstämma 2013 |
2012-11-13 | 15-7 2012 |
2012-10-19 | Kvartalsrapport 2012-Q3 |
2012-10-18 | Extra Bolagsstämma 2012 |
2012-08-31 | Kvartalsrapport 2012-Q2 |
2012-06-21 | Ordinarie utdelning WNT 0.00 SEK |
2012-06-20 | Årsstämma 2012 |
2012-05-31 | Kvartalsrapport 2012-Q1 |
2012-05-30 | Kvartalsrapport 2012-Q1 |
2012-02-28 | Bokslutskommuniké 2011 |
2011-11-25 | Extra Bolagsstämma 2011 |
2011-11-10 | Kvartalsrapport 2011-Q3 |
2011-08-31 | Kvartalsrapport 2011-Q2 |
2011-06-20 | Ordinarie utdelning WNT 0.00 SEK |
2011-06-17 | Årsstämma 2011 |
2011-05-17 | Kvartalsrapport 2011-Q1 |
2011-02-28 | Bokslutskommuniké 2010 |
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Bioteknik |
Patient recruitment for the ongoing Phase IIa clinical study NeoFox with WntResearch's drug candidate Foxy-5 continues. Despite a significant negative impact of covid-19, an aditional 12 patients were randomized during the first quarter of 2021 totaling the number of randomisez patients to 70.
The recruitmentrate of new patients in the study is currently reduced since only half of the participating clinics in the study are actively recruiting. WntResearch aims to increase the recruitmenrate during the summer by restoring full activity at all 28 participating clinics in Hungary and Spain, provided that the negative effects of covid-19 have diminished.
"It is very gratifying that so many patients are being randomized in the NeoFox study despite the ongoing covid pandemic. The relatively good recruitment rate reflects a great interest in participating in the study, not least considering that only half of the clinics are open for patient recruitment. Our goal is to be able to reach full study activity during the summer to ensure a patient base of 120 patients to perform an interim analysis on by the end of 2022. " says CEO Anders Rabbe.
For further information:
Anders Rabbe, acting CEO
Phone: +46 707 646 500
E-mail: anders.rabbe@wntresearch.com
This information was submitted for publication, through the agency of the contact person set out above, on April 14, 2021.